Cleared Traditional

K192348 - SICAT Implant V2.0

K192348 is the FDA 510(k) clearance for SICAT Implant V2.0 by Sicat GmbH & Co. KG. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 97-day FDA review.

K192348 · Sicat GmbH & Co. KG · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2019
Decision
97d
Days
Class 2
Risk

K192348 is an FDA 510(k) clearance for the SICAT Implant V2.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Sicat GmbH & Co. KG (Bonn, DE). The FDA issued a Cleared decision on December 4, 2019 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Sicat GmbH & Co. KG devices

Submission Details

510(k) Number K192348 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2019
Decision Date December 04, 2019
Days to Decision 97 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 107d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K192348.
QyScore Software
K192531 · Qynapse · Dec 2019
NemoScan
K192571 · Software Nemotec S.L. · Dec 2019
PhantomMSK Trauma
K192279 · OrthoGrid Systems, Inc. · Dec 2019
Emprint Visualization Application
K192038 · Covidien, LLC · Dec 2019
Medsynapse Ris Pacs & Medsynapse VNA
K192508 · Medsynaptic Private, Ltd. · Nov 2019
RSI-MRI+
K191278 · Multimodal Imaging Services Corporation (Dba Healthlytix) · Nov 2019